| Title | Cancer cytopathology |
| Abbreviation | Cancer cytopathol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Oncology (Q1); Cancer Research (Q2) |
| h-index | 64 |
| Overall Rank/Ranking | 2954 |
| SCImago Journal Rank (SJR) | 1.231 |
| Impact Score | 2.77 |
| Publisher | Wiley-Blackwell |
| Country | United States |
| ISSN | 1934662X, 19346638 |
| Best Quartile | Q1 |
| Coverage History | 2008-2022 |
The CANCER site is a full-text, electronic implementation of CANCER , an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY. The print and online versions of the journal are published by John Wiley & Sons, Inc.
The CANCER CYTOPATHOLOGY section targets these areas: analytic cytopathology; fine-needle aspiration; gynecologic cytopathology; immunocytochemistry; molecular diagnostics
Cancer cytopathology is a journal covering the technologies/fields/categories related to Oncology (Q1); Cancer Research (Q2). It is published by Wiley-Blackwell. The overall rank of Cancer cytopathology is 2954. According to SCImago Journal Rank (SJR), this journal is ranked 1.231. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 64. The best quartile for this journal is Q1.
The ISSN of Cancer cytopathology journal is 1934662X, 19346638. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cancer cytopathology is cited by a total of 1028 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Cancer cytopathology is 2.77, which is computed in 2023 as per its definition. Cancer cytopathology IF is decreased by a factor of 0.45 and approximate percentage change is -13.98% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Cancer cytopathology is 2.77. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.77 |
| 2021 | 3.22 |
| 2020 | 3.03 |
| 2019 | 2.96 |
| 2018 | 4.00 |
| 2017 | 3.03 |
| 2016 | 2.96 |
| 2015 | 2.96 |
| 2014 | 3.36 |
Cancer cytopathology has an h-index of 64. It means 64 articles of this journal have more than 64 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Cancer cytopathology is 1934662X, 19346638. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Cancer cytopathology is 2954. According to SCImago Journal Rank (SJR), this journal is ranked 1.231. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.231 |
| 2021 | 1.133 |
| 2020 | 1.290 |
| 2019 | 1.365 |
| 2018 | 1.571 |
| 2017 | 1.178 |
| 2016 | 1.276 |
| 2015 | 1.122 |
| 2014 | 1.150 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2954 |
| 2021 | 3344 |
| 2020 | 2937 |
| 2019 | 2623 |
| 2018 | 2065 |
| 2017 | 3416 |
| 2016 | 3033 |
| 2015 | 3759 |
| 2014 | 3531 |
Cancer cytopathology is published by Wiley-Blackwell. It's publishing house is located in United States. Coverage history of this journal is as following: 2008-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Cancer cytopathology is Cancer cytopathol.. This abbreviation ('Cancer cytopathol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Oncology (Q1); Cancer Research (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Cancer cytopathology latest impact IF is 2.77. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 4.00 (2018) and 2.77 (2022), respectively, in the last 9 years. Moreover, its average IS is 3.14 in the previous 9 years.
The Cancer cytopathology has an SJR (SCImago Journal Rank) of 1.231, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.571 in 2018 and the lowest being 1.122 in 2015. Furthermore, the average SJR of the Cancer cytopathology over the previous 9-year period stands at 3.14.
The latest h-index of the Cancer cytopathology is 64.
The Cancer cytopathology is published by the Wiley-Blackwell, with its country of publication being the United States.
The Cancer cytopathology is currently ranked 2954 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 2065 in 2018 and its lowest position of 3759 in 2015.
The standard ISO4 abbreviation for the Cancer cytopathology is Cancer cytopathol..
Cancer cytopathology is classified as a journal that the Wiley-Blackwell publishes.
The Cancer cytopathology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Cancer cytopathology is assigned the following International Standard Serial Numbers (ISSN): 1934662X, 19346638.
The best quartile for the Cancer cytopathology is Q1 (2022).
The Cancer cytopathology coverage history can be summarized as follows: 2008-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Istanbul University - Journal of Electrical and Electronics Engineering | journal | 24654 | University of Istanbul | 0 | 0.00 |
| Journal of International Financial Management and Accounting | journal | 6179 | Wiley-Blackwell Publishing Ltd | 42 | 6.09 |
| Journal of Applied Business Research | journal | 23890 | 29 | 0.28 | |
| Libyan Studies | journal | 16122 | Cambridge University Press | 8 | 0.45 |
| Oral Radiology | journal | 9461 | Springer Japan | 20 | 2.06 |
| Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining | conference and proceedings | 4334 | 192 | 0.00 | |
| Expert Review of Clinical Pharmacology | journal | 5241 | Taylor and Francis Ltd. | 53 | 4.10 |
| Journal of Medical Toxicology | journal | 8639 | Springer New York | 55 | 2.01 |
| International Journal of Data Mining and Bioinformatics | journal | 23114 | Inderscience Enterprises Ltd. | 24 | 0.40 |
| Indian Journal of Rheumatology | journal | 18638 | Wolters Kluwer Medknow Publications | 15 | 0.44 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.77 |
| 2021 | 3.22 |
| 2020 | 3.03 |
| 2019 | 2.96 |
| 2018 | 4.00 |
| 2017 | 3.03 |
| 2016 | 2.96 |
| 2015 | 2.96 |
| 2014 | 3.36 |
